Lawsuits have been filed that allege Elmiron, which is a drug that can treat chronic bladder infection called interstitial cystitis, causes vision damage.
A federal judicial panel has transferred nearly 130 lawsuits to New Jersey brought over Janssen Pharmaceuticals’ pharmaceutical drug Elmiron.
Elmiron, used to treat chronic bladder infection called interstitial cystitis, causes eye problems.
Lawyers filed the Elmiron cases this year as Jansse changed the label to the drug, which has been on the market since 1996, cautioning about “retinal pigmentary changes.”
There have been studies at Emory Eye Center, Kaiser Permanente and Harvard that found Elmiron could cause vision injuries.
Janssen’s attorney, from a law firm in Houston, wrote that his client supported an MDL despite “the growing trend in recent years that the mere formation of multidistrict litigation can result in the filing of meritless claims in an effort to increase plaintiff inventories and encourage settlement.”